GERMANY VETERINARY HEALTHCARE MARKET 2014 - 2019 Market Shares, Forecasts & Trends
mordorintelligence.com
RESEARCH METHODOLOGY 1) Secondary Research: Information was collected from a number of public and paid data sources. Public sources involved Government websites, publications from the Animal healthcare programs of different countries, company annual reports, white papers and research publications by recognized industry experts. Paid data sources include authentic industry databases. 2) Primary Research: After collecting data from secondary sources, primary interviews were conducted with stakeholders at different points of the animal healthcare products manufacturers, distributors, ingredient suppliers, companies producing veterinary products and key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill any gaps in data. 3) Market Analysis: The market analysis phase involves analyzing the collected data, market breakdowns and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at a close estimate. 4) Expert Validation: The market analysis data is verified and validated by a number of experts, both in-house and external. 5) Report Writing: After the data is curated through the process, our analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire business ecosystem in a single report.
VIEW THIS REPORT ON OUR WEBSITE Germany Veterinary Healthcare Market | Sample
TABLE OF CONTENTS 1. INTRODUCTION
1
1.1. Methodology
1
1.2. Definition of the market
2
2. KEY FINDINGS OF THE STUDY
3
3 Germany Veterinary Healthcare Market – Overview
4
4. GLOBAL MARKET ANALYSIS
5
4.1. Livestock Industry Trend
5
4.2 Farm animals Health Trend
7
4.3 Companion animals health trend
8
4.4. Threshold matters of the Industry
9
4.5. Factors Affecting the Global Market
10
4.5.1. Drivers
10
4.5.2. Restraints
17
4.5.3. Opportunities
22
4.6. Porters Analysis
23
4.6.1. Bargaining power of Buyers
24
4.6.2. Bargaining power of Suppliers
25
4.6.3. Degree of Competition
26
4.6.4. Threat of new entrants
27
4.6.5. Threat of Substitutes
28
4.7. Global Regulatory Environment-Impact Analysis
29
4.8. Value Chain Analysis
Germany Veterinary Healthcare Market | Sample
VIEW THIS REPORT ON OUR WEBSITE
5.Germany’s Share in the Europe Veterinary health care market.
30
6. Germany’s Animal Veterinary care market- Market Segmentation by products
31
6.1 Vaccines
33
6.2 Anti-Infectives
35
6.3 Paraciticides
39
6.4 Medicinal Feed Additives
42
6.5 Other Phamaceuticals
44
7. Germany’s Veterinary health care market- Market Segmentation by Animals 7.1 Farm animal health market
45 45
7.1.1 Poultry health market
46
7.1.2 Swine health market
48
7.1.3 Fish health market
50
7.1.4 Cattle health market
52
7.1.5 Sheep health market
54
7.2 Companion animal health market
55
7.2.1 Dogs and Cats Market
57
7.2.2 Horse health market
59
8. The future of the industry-Expert View
60
9. Key players’ profile – Global
61
9.1 Zoetis Animal Healthcare
62
9.2 Merck Ltd.
64
9.3 Merial( Animal Health division of Sanofi)
66
9.4 Elanco Animal Health
67
Germany Veterinary Healthcare Market | Sample
VIEW THIS REPORT ON OUR WEBSITE
9.5 Bayer Animal Health
69
9.6 Novartis Animal Health.
70
9.10 BOEHRINGER INGELHEIM
71
10. Appendix
72
10.1.Abbreviations
73
10.2.Sources
74
10.3.Bibliography
76
10.4.Disclaimer
77
Germany Veterinary Healthcare Market | Sample
VIEW THIS REPORT ON OUR WEBSITE
MARKET DEFINITION Animal health market is a growing industry comprising companion animals and Farm animals. Companion animals are those which people tame or adopt for companionship, house/ office guards, and farm animals are raised for meat and milk related products. Companion animals include dogs, cats and horses. Farm animals are Cattle, Poultry, Swine, Fish, etc. Major companies in the market are actively producing and manufacturing animal health care products, pharmaceuticals and others. This market research report provides in-depth market intelligence of animal health care industry. Germany veterinary healthcare market is growing because of the increasing population of both the types of animals. Increasing consumption of meat and milk products, new diseases in animals and transfer of these diseases from animals to human beings are propelling animal healthcare market globally. The changing lifestyle, increasing per capita income and increasing population has led to an increase in meat consumption. The demand of animal rich protein such as meat, eggs and milk is rising and due to this, population of farm animals is also increasing. Based on the products, market is divided into vaccines, paraciticides, anti-infectives and medicinal feed additives. Medicinal feed additives are growing at a faster pace because of people’s awareness of animal health and the connection between animal health and human health. The pharmaceutical and vaccine market is growing due to increasing number of diseases in animal and increasing concern of animal immunization.
Germany Veterinary Healthcare Market | Sample
VIEW THIS REPORT ON THE WEBSITE
2 | Mordor Intelligence
VIEW THIS REPORT ON OUR WEBSITE
GERMANY VETERINARY HEALTHCARE MARKET Germany veterinary market is a relatively small market. About 10 MNCs and 20 medium-sized local manufacturers of veterinary medicine are competing in this market. The market is continuously growing for the last 10 years, however, mostly in moderate percentages. There are approximately 13.7 million heads of cattle; 26.2 millions of pigs; 2.1 millions of sheep, 446 million units for chicken raising and 48 millions of hens. About 4.000 pet consultancies attend 4.7 million dogs; 7 million cats and about 1 million horses. German veterinary healthcare market consists of vaccines, paraciticides, anti-infectives, medicinal feed additives and other pharmaceuticals. There are around 30 additional medium sized German companies which are working in other areas of animal health for e.g. veterinarian diagnostics, surgical instruments, animal care products and their sales. Their sales value estimated in Germany is about 240 million Euros per year. German veterinary healthcare market is US $1.01 billion in 2014 and is estimated to reach US$1.62 billion by 2019 at a CAGR of 9.91%. This market is in a process of strong diversification. Within this market, functional products which support defined physiological needs of the animals and the LifeCycle-Products which respond to special nutritional needs of pets are gaining the customer’s acceptance.
Germany Veterinary Healthcare Market 2
$ billion
1.5 1 0.5 0 2011
2012
2013
2014
2019
Source: Mordor Intelligence Analysis
Germany Veterinary Healthcare Market | Sample
4 | Mordor Intelligence
VIEW THIS REPORT ON OUR WEBSITE
MARKET DRIVERS GREATER LIVESTOCK PRODUCTION The demand for information on livestock production is growing, both in the sense of demands expressed by the producers themselves, and in the more general sense of a growing potential for increasing production through the delivery of information. The livestock sector is very dynamic globally. Rapidly increasing demand for livestock products in developing countries is the major factor for increased livestock production. In developed countries, demand for livestock products is stagnating, while many production systems are increasing their efficiency and environmental sustainability. Developments in breeding, nutrition and animal health will continue to contribute to increasing population of livestock. Demand for livestock products in the future could be heavily moderated by socio-economic factors such as human health concerns and changing socio-cultural values. The global livestock sector is characterized by a dichotomy between developing and developed countries. Total meat production in the developing world tripled between 1980 and 2002, from 45 to 134 million tons (World Bank 2009). Every year the number of farms and heads of animals are increasing in Germany. In 2010, the number of farms and heads of animals were approximately 216,100 and this number is estimated to increase in the coming years owing to increasing demand of livestock population in this region.
Germany Veterinary Healthcare Market | Sample
10 | Mordor Intelligence
VIEW THIS REPORT ON OUR WEBSITE
GERMANY FARM AND COMPANION VETERINARY HEALTH MARKET Livestock is the main source of income in agriculture. Approx. 60 percent of the revenue from German agriculture comes from the sale of livestock farming products. Pigs In May 2009, roughly 26.9 million pigs were kept in approx. 67,600 farms in Germany. This implies the number of pigs has increased by 0.6 percent as compared to the previous year and the number is expected to increase in forecast period 2014-2019. There was a slight rise in the number of breeding cows of 0.5 percent to 2.3 million in the last six months. With a share of almost 20 percent, Germany is the largest pork producer in the EU and with 15 percent, the second largest producer of beef and veal. Talking about companion animal market in Germany, there are 8 million cats, over 5 million dogs and another 5 million small animals. Both companion and Farm animal market consists of vaccines, paraciticides, anti-infectives, medicinal feed additives etc. Animal vaccines is the fastest growing market estimated to reach US$ 0.925 billion in 2019 with a healthy CAGR of 10.28% , followed by Anti-infectives market growing at a CAGR of 9.54%. Germany Farm animal health market is US$ 0.369 in 2014 and is estimated to reach US$ 0.587 by 2019.
Germany Farm Animal Healthcare Market 0.7 0.6
DATA HIDDEN FROM VIEW
$ billion
0.5 0.4 0.3 0.2 0.1 0 2011
2012
2013
2014
2019
Source: Mordor Intelligence Analysis
Germany Veterinary Healthcare Market | Sample
45 | Mordor Intelligence
VIEW THIS REPORT ON OUR WEBSITE
Germany Comapnion Animal Healthcare Market 1.2
$ billion
1
DATA HIDDEN FROM VIEW
0.8 0.6 0.4 0.2 0 2011
2012
2013
2014
2019
Source: Mordor Intelligence Analysis
Germany Veterinary Healthcare Market Share
Anit-Infectives
Source: Mordor Intelligence Analysis
Germany Veterinary Healthcare Market | Sample
46 | Mordor Intelligence
VIEW THIS REPORT ON OUR WEBSITE
COMPANY PROFILES BAYER ANIMAL HEALTH BUSINESS OVERVIEW Bayer HealthCare Animal Health is one of the world’s leading research-based veterinary medicine companies. We rank among the top five animal health companies in the world, and are a global leader in parasiticides and companion animal products. Bayer HealthCare's Animal Health Division is the maker of Advantage Multi (imidacloprid + moxidectin) Topical Solution for dogs and cats, Advantage flea control for cats and dogs and K9 Advantix, a flea, tick, and mosquito control product for dogs. Advantage Multi, K9 Advantix and Advantage are trademarks of Bayer. The division specializes in parasite control and prescription pharmaceuticals for dogs, cats, horses, and cattle. North American operation for the Animal Health Division is headquartered in Shawnee, Kansas. Bayer Animal Health is a division of Bayer HealthCare LLC, one of the world's leading healthcare companies. FINANCIAL OVERVIEW Bayer HealthCare’s Animal Health Divison generated a revenue of about $1.716 billion for the year 2013. There revenue increased by 0.2% compared to that of the year 2012 where the revenue generated was $1.712 billion. PRODUCTS
Advantage® II controls against all flea life stages. Kills through contact. Fleas don't have to bite to die. Advantage® II is a convenient monthly topical application that is for use on dogs and puppies 7 weeks of age and older, weighing 3 lbs or more.
Advantage® Treatment Shampoo for dogs & puppiesto kill fleas and ticks on contact. For use on dogs and puppies over 12 weeks.
Germany Veterinary Healthcare Market | Sample
69 | Mordor Intelligence
VIEW THIS REPORT ON OUR WEBSITE
Seresto®, the performance you expect from a topical in an easy-to-use collar with sustained release technology that offers 8 months of continuous protection against fleas and ticks. For use on dogs and puppies 7 weeks of age and older.
K9 Advantix® II offers broad spectrum protection against fleas, ticks and mosquitoes, too. It is specifically formulated for dogs and comes in a convenient, monthly topical application that not only kills but also repels fleas, ticks and mosquitoes. K9 Advantix®IIalso kills ALL life stages of fleas, repels biting flies and kills lice. K9 Advantix® II is for use on dogs 7 weeks and older and weighing 4 lbs. or more. K9 Advantix® II is for use on dogs only.
Seresto®, the performance you expect from a topical in an easy-to-use collar with sustained release technology that offers 8 months of continuous protection against fleas and ticks. For use on cats and kittens 10 weeks of age and older.
Advantage Multi® for Cats (imidacloprid+moxidectin), your convenient solution for broad spectrum parasite protection. It kills adult fleas, treats flea infestations, treats and controls common intestinal parasites (hookworms and roundworms) and ear mites, as well as prevents heartworm disease. For use on cats and kittens at least 9 weeks of age and weighing at least 2 lbs.
Germany Veterinary Healthcare Market | Sample
70 | Mordor Intelligence
VIEW THIS REPORT ON OUR WEBSITE
BOEHRINGER INGELHEIM BUSINESS OVERVIEW The pharmaceutical company Boehringer Ingelheim was founded in 1885 by Albert Boehringer (18611939) in Ingelheim am Rhein. From its beginnings in 1885 when it employed just 28 people in NiederIngelheim, the company has since become a global enterprise. As part of research and development activities for innovative drugs, the company focuses primarily on the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 142 affiliates and more than 47,400 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel medications of high therapeutic value for human and veterinary medicine. FINANCIAL OVERVIEW The revenue generated by the animal health division at Boehringer for the year is $1.479 billion. The company observed a net revenue increase of 9.47% compared to the revenue generated in the year 2012. The revenue generated for the year 2012 was $1.351 billion. PRODUCTS
Enterisol® Ileitis: For active immunisation of pigs against ileitis due to Lawsonia intracellularis infection.
Ingelvac® Aujeszky MLV: Ingelvac® Aujeszky MLV is a gE®-deleted vaccine based on the Bartha K61 strain which is licensed for active immunisation and eradication of Pseudorabies virus in swine production units.
Germany Veterinary Healthcare Market | Sample
71 | Mordor Intelligence
VIEW THIS REPORT ON OUR WEBSITE
Ingelvac CircoFLEX®: Ingelvac CircoFLEX® is a pig vaccine registered for use as a single vaccination around weaning against the diseases associated with the porcine circovirus type-2 (PCV2). This includes the reduction of disease related clinical signs like mortality, weight loss and lesions in the lymphoid tissue.
Metacam®: For use in non-infectious locomotor disorders to reduce the symptoms of lameness and inflammation. For adjunctive therapy in the treatment of puerperal septicaemia and toxaemia (mastitis-metritis-agalactia syndrome) with appropriate antibiotic therapy. For the relief of post operative pain associated with minor soft tissue surgery such as castration.
Benestermycin® / Mamyzin® / A Mamyzin® Secado / Umpimycin®: For the treatment of subclinical infections present at drying off and assistance in preventing new infections as well as acute clinical mastitis during the dry period in dairy cattle.
Germany Veterinary Healthcare Market | Sample
72 | Mordor Intelligence
DISCLAIMER Mordor Intelligence Reports and their contents, including all the analysis and research containing valuable market information, are provided to a select group of customers in response to orders. Our customers acknowledge when ordering that Mordor Intelligence strategic analysis services are for our customers’ internal use and not for general publication or disclosure to third parties.
Quantitative market information is based primarily on interviews and therefore, is subject to fluctuation. Mordor Intelligence takes no responsibility for any incorrect information supplied to us by manufacturers or users.
No part of this strategic analysis service may be given, lent, resold or disclosed to non-customers without written permission. Reproduction and/or transmission in any form and by any means including photocopying, mechanical, electronic, recording or otherwise, without the permission of the publisher is prohibited.
ABOUT US Mordor Intelligence is a global market research and consulting firm. Our singular focus is to provide research insights for business success.
Our research team has expertise in diverse fields like Agriculture, Healthcare, ICT, Chemicals, Manufacturing, Logistics, Electronics and Automotive. However diverse the expertise maybe, everyone in our team shares one common trait - we love data and we love providing solutions to clients using that data even more. Seeing your business flourish based on our solutions and strategy is what we love the most.
For information regarding permissions and sales, please contact: info@mordorintelligence.com
Germany Veterinary Healthcare Market | Sample
VIEW THIS REPORT ON OUR WEBSITE
!
Mordor Intelligence LLP No. 30, Padma Nilaya, Chola Nagar Bangalore, Karnataka, India 560032 +1 781 881 1110 | info@mordorintelligence.com
Copyright Š 2014 Mordor Intelligence LLP All Rights Reserved. This document contains highly confidential information and is the sole property of Mordor Intelligence LLP. No part of it may be circulated, copied, quoted, or otherwise reproduced without the approval of Mordor Intelligence LLP.
7 | Mordor Intelligence
!